[{"address1": "302 East Pettigrew St.", "address2": "Suite A-100", "city": "Durham", "state": "NC", "zip": "27701", "country": "United States", "phone": "919 314 5512", "fax": "480 393 5553", "website": "https://precisionbiosciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-3243 for the treatment of m.3243 associated mitochondrial myopathy. In addition, the company develops PBGENE-NVS (insertion) for sickle cell and beta thalassemia diseases; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LIVER (insertion), a liver directed target; PBGENE-CNS (excision), a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with Novartis Pharma AG to discover and develop in vivo gene editing products; TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; and iECURE, Inc. to develop ARCUS-based gene-insertion therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.", "fullTimeEmployees": 102, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael  Amoroso", "age": 46, "title": "President, CEO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1094351, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jefferson J. Smith Ph.D.", "age": 51, "title": "Co-Founder & Chief Research Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 640195, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Alexander Kelly R.Ph.", "age": 57, "title": "CFO & Principal Accounting Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 671382, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cassie  Gorsuch Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Naresh  Tanna", "title": "Chief of Staff to CEO & Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dario  Scimeca J.D.", "age": 49, "title": "General Counsel & Secretary", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 576432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Juli  Blanche", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cindy  Atwell", "title": "Chief Development & Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil  Leatherbury M.S.", "title": "Senior VP and Head of Chemistry, Manufacturing & Controls", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 4.93, "open": 4.95, "dayLow": 4.93, "dayHigh": 5.09, "regularMarketPreviousClose": 4.93, "regularMarketOpen": 4.95, "regularMarketDayLow": 4.93, "regularMarketDayHigh": 5.09, "payoutRatio": 0.0, "beta": 1.607, "forwardPE": -0.7463127, "volume": 56172, "regularMarketVolume": 56172, "averageVolume": 129080, "averageVolume10days": 74690, "averageDailyVolume10Day": 74690, "bid": 4.98, "ask": 5.11, "bidSize": 1, "askSize": 1, "marketCap": 59642172, "fiftyTwoWeekLow": 3.61, "fiftyTwoWeekHigh": 9.813, "allTimeHigh": 710.1, "allTimeLow": 3.61, "priceToSalesTrailing12Months": 47.29752, "fiftyDayAverage": 4.8404, "twoHundredDayAverage": 4.926, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 26845174, "profitMargins": 0.0, "floatShares": 10553482, "sharesOutstanding": 11786991, "sharesShort": 1157753, "sharesShortPriorMonth": 1220193, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.09819999, "heldPercentInsiders": 0.112959996, "heldPercentInstitutions": 0.44237998, "shortRatio": 14.99, "shortPercentOfFloat": 0.1012, "impliedSharesOutstanding": 11786991, "bookValue": 2.926, "priceToBook": 1.7293233, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -78255000, "trailingEps": -10.15, "forwardEps": -6.78, "lastSplitFactor": "1:30", "lastSplitDate": 1707868800, "enterpriseToRevenue": 21.289, "enterpriseToEbitda": -0.304, "52WeekChange": -0.43526787, "SandP52WeekChange": 0.1529237, "quoteType": "EQUITY", "currentPrice": 5.06, "targetHighPrice": 60.0, "targetLowPrice": 19.0, "targetMeanPrice": 36.33333, "targetMedianPrice": 30.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 62242000, "totalCashPerShare": 5.281, "ebitda": -88168000, "totalDebt": 29445000, "quickRatio": 4.587, "currentRatio": 5.178, "totalRevenue": 1261000, "debtToEquity": 86.466, "revenuePerShare": 0.141, "returnOnAssets": -0.41, "returnOnEquity": -1.43893, "grossProfits": 1261000, "freeCashflow": -26599750, "operatingCashflow": -63918000, "revenueGrowth": -1.0, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -1215.3889, "financialCurrency": "USD", "symbol": "DTIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 2.63692, "regularMarketPrice": 5.06, "shortName": "Precision BioSciences, Inc.", "longName": "Precision BioSciences, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1553779800000, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1758920148, "regularMarketTime": 1758916801, "exchange": "NCM", "messageBoardId": "finmb_41018856", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": 0.0, "postMarketPrice": 5.06, "postMarketChange": 0.0, "regularMarketChange": 0.13, "regularMarketDayRange": "4.93 - 5.09", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 129080, "fiftyTwoWeekLowChange": 1.45, "fiftyTwoWeekLowChangePercent": 0.40166208, "fiftyTwoWeekRange": "3.61 - 9.813", "fiftyTwoWeekHighChange": -4.753, "fiftyTwoWeekHighChangePercent": -0.48435748, "fiftyTwoWeekChangePercent": -43.526787, "earningsTimestamp": 1754539200, "earningsTimestampStart": 1754539200, "earningsTimestampEnd": 1754539200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -10.15, "epsForward": -6.78, "epsCurrentYear": -7.9, "priceEpsCurrentYear": -0.6405063, "fiftyDayAverageChange": 0.21959972, "fiftyDayAverageChangePercent": 0.045368094, "twoHundredDayAverageChange": 0.13399982, "twoHundredDayAverageChangePercent": 0.027202561, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Precision BioSciences", "trailingPegRatio": null, "__fetch_time": "2025-09-27"}]